BioScrip Schedules Release of Third Quarter 2018 Financial Results and Conference Call
24 Octobre 2018 - 3:00PM
BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced that the Company will issue
its financial results press release for the third quarter ended
September 30, 2018 on Tuesday, November 6, 2018 before the opening
of the U.S. financial markets.
Daniel E. Greenleaf, President and Chief Executive Officer, and
Stephen Deitsch, Senior Vice President, Chief Financial Officer and
Treasurer, will host a conference call as follows:
Date |
November 6, 2018 |
Time |
9:00 a.m. ET |
Toll free (U.S.) |
(877) 423-9820 |
International |
(201) 493-6749 |
Webcast (live and replay) |
http://www.investorcalendar.com/event/39474 |
|
or |
|
www.bioscrip.com |
The online replay will be available within two hours of the
call’s completion in the Investor Relations section of BioScrip’s
web site at: www.bioscrip.com.
About BioScrip, Inc.BioScrip, Inc. is the
largest independent national provider of infusion and home care
management solutions, with approximately 2,100 teammates and nearly
70 service locations across the U.S. BioScrip partners with
physicians, hospital systems, payors, pharmaceutical manufacturers
and skilled nursing facilities to provide patients access to
post-acute care services. BioScrip operates with a commitment to
bring customer-focused pharmacy and related healthcare infusion
therapy services into the home or alternate-site setting. By
collaborating with the full spectrum of healthcare professionals
and the patient, BioScrip provides cost-effective care that is
driven by clinical excellence, customer service, and values that
promote positive outcomes and an enhanced quality of life for those
it serves.
Investor
Contacts |
|
Stephen Deitsch |
Kalle
Ahl, CFA |
Chief
Financial Officer & Treasurer |
The
Equity Group |
T:
(720) 697-5200 |
T:
(212) 836-9614 |
stephen.deitsch@bioscrip.com |
kahl@equityny.com |
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024